TPCW
JAZZ icon

TD Private Client Wealth’s Jazz Pharmaceuticals JAZZ Stock Holding History

TD Private Client Wealth’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$536K Sell
2,836
-135
-5% -$23.6K 0.01% 480
2025
Q4 		$505K Buy
2,971
+711
+31% +$109K 0.01% 482
2025
Q3 		$298K Sell
2,260
-572
-20% -$68.6K 0.01% 584
2025
Q2 		$301K Buy
2,832
+486
+21% +$52.8K 0.01% 566
2025
Q1 		$291K Buy
+2,346
New +$306K 0.01% 536
2024
Q4 		– Sell
-587
Closed -$65.4K – 1329
2024
Q3 		$65.4K Sell
587
-73
-11% -$8K ﹤0.01% 785
2024
Q2 		$70.4K Sell
660
-690
-51% -$75.9K ﹤0.01% 744
2024
Q1 		$163K Buy
1,350
+1,329
+6,329% +$163K 0.01% 620
2023
Q4 		$2.58K Hold
21
– – ﹤0.01% 1144
2023
Q3 		$2.72K Hold
21
– – ﹤0.01% 1143
2023
Q2 		$2.6K Hold
21
– – ﹤0.01% 1155
2023
Q1 		$3.07K Hold
21
– – ﹤0.01% 1136
2022
Q4 		$3.35K Hold
21
– – ﹤0.01% 1099
2022
Q3 		$2.8K Sell
21
-52
-71% -$7.91K ﹤0.01% 1093
2022
Q2 		$11.4K Sell
73
-6
-8% -$924 ﹤0.01% 990
2022
Q1 		$12.3K Hold
79
– – ﹤0.01% 1021
2021
Q4 		$10.1K Sell
79
-18
-19% -$2.37K ﹤0.01% 912
2021
Q3 		$12.6K Hold
97
– – ﹤0.01% 897
2021
Q2 		$17.2K Hold
97
– – ﹤0.01% 860
2021
Q1 		$15.9K Hold
97
– – ﹤0.01% 851
2020
Q4 		$16K Hold
97
– – ﹤0.01% 801
2020
Q3 		$13.8K Hold
97
– – ﹤0.01% 769
2020
Q2 		$10.7K Buy
97
+7
+8% +$774 ﹤0.01% 792
2020
Q1 		$8.98K Sell
90
-3
-3% -$388 ﹤0.01% 767
2019
Q4 		$13.9K Buy
+93
New +$12.7K ﹤0.01% 730

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

TD Private Client Wealth's JAZZ Position: Q1 2026 in Review

TD Private Client Wealth reduced its Jazz Pharmaceuticals (JAZZ) stake by 4.5% in Q1 2026, selling an estimated $23.6K and leaving 2,836 shares worth $536K. The position accounts for 0.01% of the portfolio, ranked #480.

TD Private Client Wealth first reported a position in JAZZ in Q4 2019 and has held it in 25 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • TD Private Client Wealth held 2,836 shares of Jazz Pharmaceuticals worth $536K as of Q1 2026.
  • TD Private Client Wealth sold 135 Jazz Pharmaceuticals shares in Q1 2026, an estimated $23.6K.
  • Jazz Pharmaceuticals made up 0.01% of TD Private Client Wealth's portfolio in Q1 2026, its #480 holding.
  • TD Private Client Wealth first reported a position in Jazz Pharmaceuticals in Q4 2019 and has held it in 25 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on TD Private Client Wealth's 13F filing for Q1 2026, filed 27 Apr 2026.